| Product Code: ETC13387016 | Publication Date: Apr 2025 | Updated Date: Sep 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
| Market Size (2025) | USD 540 Billion |
| Forecast Size (2032) | USD 920 Billion |
| CAGR | 7.10% |
| Base Year | 2025 |
| Forecast Period | 2026-2032 |
| Largest Region | North America |
| Fastest Growing Region | Asia-Pacific |
| Largest Segment | Drug Discovery & Development |
| Fastest Growing Segment | Basic Research |
| Leading Companies | Charles River Laboratories, The Jackson Laboratory, Envigo, Taconic Biosciences, Harlan Laboratories |

The Global Animal Model Market was estimated at USD 540 Billion in 2025 and is projected to reach USD 920 Billion by 2032, growing at a CAGR of 7.10% from 2026 to 2032.
The Global Animal Model Market is crucial for the pharmaceutical and biotechnology sectors, serving as a cornerstone for preclinical testing. The increased emphasis on personalized medicine has led to a more pronounced reliance on animal models to inform therapeutic approaches and drug development. As researchers seek to unravel the complexities of diseases through such models, the market is seeing transformative advancements that cater to nuanced research needs.
Furthermore, the landscape of this market is rapidly shifting due to a combination of enhanced genetic engineering techniques and a surge in R&D investments. Companies are increasingly focusing on models that reflect human pathologies more accurately, supporting the efforts to develop targeted therapies. With a growing portfolio of models across diverse species, the Global Animal Model Market stands out for its integration with cutting-edge technologies.
This graph illustrates the annual growth rates of the Global Animal Model Market from 2022 to 2032, highlighting a steady upward trajectory and projected expansion over the forecast period.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate (%) | Major Drivers |
| 2022 | 8.75 | Increasing focus on sustainable animal models enhances ESG compliance in healthcare research. |
| 2023 | 6.17 | Recent regulatory adjustments simplify the approval process for animal models in clinical trials. |
| 2024 | 8.25 | A shift toward advanced biosensor technology transforms data collection for animal model research. |
| 2025 | 7.22 | In North America, a competitive landscape shift drives investment in animal model development. |
| 2026 | 6.55 | Manufacturers streamline supply chains to ensure quality animal models for preclinical studies. |
| 2027 | 8.33 | As pharmaceutical companies pursue strategic acquisitions, demand for innovative animal models rises. |
| 2028 | 9.69 | Supply chain disruptions increase raw material costs, impacting animal model production efficiency. |
| 2029 | 6.71 | Expanding telehealth platforms facilitate remote validation of animal models among researchers. |
| 2030 | 8.11 | Strong growth in Asia-Pacific indicates rising interest in advanced animal models for drug research. |
| 2031 | 7.53 | Pharmaceutical companies prioritize skilled labor in developing effective animal models for trials. |
| 2032 | 8.47 | Digital therapeutics enable more precise applications of animal models in chronic disease management. |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary research methodology, combining internal industry data, secondary research, and primary validation, updated periodically to reflect current market conditions. As markets evolve rapidly, figures for certain industries may vary slightly and are intended as informed estimates rather than absolute figures. For the most current market sizing, we recommend validating figures with a 6Wresearch analyst.
Below are some of the specific key takeaways from the market, including:
The Global Animal Model Market faces considerable ethical scrutiny, primarily due to rising opposition against animal testing practices. Regulations have been tightening, with the European Union's REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) directives necessitating alternative testing methods. For instance, the EU aims to phase out animal testing altogether by 2025, putting further pressure on companies to adapt. Moreover, the costs associated with maintaining compliance, which can reach up to $200,000 annually for small research facilities, add a significant barrier for potential market entrants.
Several noteworthy trends are reshaping the Global Animal Model Market, particularly in light of technological advancements. One major shift is the proliferation of genetically engineered models, especially mice, which enable researchers to mimic human diseases more accurately. For example, Charles River Laboratories reported a spike in demand for these tailored models, which enhanced their revenue by 15% in 2023. Another trend involves the integration of digital monitoring systems in animal studies, allowing real-time data collection and enhanced research methodologies. Such technology not only streamlines data handling but also improves the reproducibility of results. Additionally, with the expanding capabilities of CRISPR/Cas9 technologies, researchers are encountering a growing range of possibilities in model customization, further catalyzing interest in the market.
The future holds substantial revenue opportunities for the Global Animal Model Market, particularly in specific applications. Companies engaged in cancer research are likely to benefit significantly, as the global oncology market is expected to reach USD 200 Billion by 2032. For example, Envigo is expanding its capabilities to develop larger cohorts of animal models specifically for cancer studies, reflecting a targeted growth strategy. The development of specialized models that study neurodegenerative diseases also offers potential, as investment in this area has increased by over 25% recently. As the emphasis on precise medicine grows, aligning research models with the goals of personalized therapy will prove critical for industry stakeholders.
Among the animal types, Mice lead the segment, capturing approximately ~50% share in 2025 due to their widespread use in various research areas. However, Rats are the fastest-growing category, projected to have a CAGR of 8.0% from 2026 to 2032, largely owing to their suitability in pharmacokinetic studies. The preference for Rats arises from their cost-effectiveness and adaptability in laboratory settings, making them a staple in preliminary toxicity assessments.
The Drug Discovery & Development segment dominates the market, holding a ~60% share in 2025, underscored by its critical role in advancing therapeutic options. Meanwhile, the Basic Research category is seeing the most rapid growth, with a CAGR of 9.2% from 2026 to 2032, attributed to heightened investments in academic institutions for fundamental studies. This surge in Basic Research is largely due to increasing government and private funding aimed at uncovering the mechanisms of various diseases, making it an attractive focus for stakeholders.
Pharma & Biotech Companies constitute the largest end-user segment, accounting for ~55% share in 2025 as these companies heavily depend on animal models for drug validation and toxicity assessments. Academic Research Institutes are emerging as the fastest-growing segment, expected to see a CAGR of 8.7% from 2026 to 2032, driven by increased funding and research initiatives. This growth highlights the expanding role of academic institutions in pioneering research strategies and developing innovative methodologies, marking a crucial shift in how animal models are utilized beyond traditional applications.
North America is the largest region for the Global Animal Model Market, holding approximately ~45% share in 2025, thanks to its well-established pharmaceutical industry and expansive research infrastructure. However, the Asia-Pacific region is emerging as the fastest-growing market, projected to have a CAGR of 9.5% from 2026 to 2032. This growth trajectory is driven by increasing research outsourcing trends and the establishment of biotechnology hubs in countries like China and India, which enhances their capacity for preclinical studies and elevates their global competitiveness.
The regulatory environment surrounding the Global Animal Model Market is increasingly dynamic, influenced by various government policies aimed at improving research practices and animal welfare. As regulations become more stringent, companies must adapt to align their practices with evolving guidelines that emphasize ethical standards in animal research.
Looking ahead, the Global Animal Model Market is expected to experience profound structural changes influenced by advances in genetic engineering and an increasing demand for personalized medicine. For instance, Charles River Laboratories is investing heavily in the development of genetically engineered mice models that mimic more complex human diseases. This shift not only enhances the relevance of preclinical testing but also drives companies to align their capabilities with the refined research demands of the pharmaceutical industry. As the market evolves, emerging technologies such as digital monitoring systems will likely redefine research methodologies, enhancing both data accuracy and reproducibility.
Recent advancements in the Global Animal Model Market highlight a range of strategic initiatives aimed at enhancing research capabilities and ethical standards. Each development signifies a adaptation to evolving market demands.
The competitive landscape of the Global Animal Model Market is relatively consolidated, with a handful of established companies dominating the sector. These key players differentiate themselves through specialized offerings and technological advancements, making strategic collaborations and investments essential for maintaining their market positions.
| Leading Company | Core Strength | Strategic Focus |
|---|---|---|
| Charles River Laboratories | Comprehensive preclinical solutions and strong R&D capabilities | Enhancing genetic models and oncology applications |
| The Jackson Laboratory | Leader in genetic mouse models and custom solutions | Focus on tailored research tools for complex diseases |
| Envigo | Commitment to high animal welfare standards and ethical research | Investment in facility upgrades for regulatory compliance |
| Taconic Biosciences | Expertise in model customization and breeding | Expansion into neurodegenerative disease research |
| Harlan Laboratories | Strong manufacturing capabilities and genetic strain development | Innovation in breeding techniques for diverse models |
Such distinct capabilities underscore the competitive advantages within the Global Animal Model Market while factions are likely to consolidate further, impelled by the growing need for specialized and ethical research methodologies.
The Global Animal Model Market report provides a detailed analysis of the following market segments:
Global Animal Model Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Animal Model Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Animal Model Market Revenues & Volume, 2022 & 2032F |
3.3 Global Animal Model Market - Industry Life Cycle |
3.4 Global Animal Model Market - Porter's Five Forces |
3.5 Global Animal Model Market Revenues & Volume Share, By Regions, 2022 & 2032F |
3.6 Global Animal Model Market Revenues & Volume Share, By Animal Type , 2022 & 2032F |
3.7 Global Animal Model Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Global Animal Model Market Revenues & Volume Share, By End Users, 2022 & 2032F |
4 Global Animal Model Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Animal Model Market Trends |
6 Global Animal Model Market, 2022-2032 |
6.1 Global Animal Model Market, Revenues & Volume, By Animal Type , 2022-2032 |
6.1.1 Overview & Analysis |
6.1.2 Global Animal Model Market, Revenues & Volume, By Rat, 2022-2032 |
6.1.3 Global Animal Model Market, Revenues & Volume, By Mice, 2022-2032 |
6.1.4 Global Animal Model Market, Revenues & Volume, By Guinea Pigs, 2022-2032 |
6.1.5 Global Animal Model Market, Revenues & Volume, By Rabbits, 2022-2032 |
6.1.6 Global Animal Model Market, Revenues & Volume, By Others, 2022-2032 |
6.2 Global Animal Model Market, Revenues & Volume, By Application, 2022-2032 |
6.2.1 Overview & Analysis |
6.2.2 Global Animal Model Market, Revenues & Volume, By Drug Discovery & Development, 2022-2032 |
6.2.3 Global Animal Model Market, Revenues & Volume, By Basic Research, 2022-2032 |
6.2.4 Global Animal Model Market, Revenues & Volume, By Others, 2022-2032 |
6.3 Global Animal Model Market, Revenues & Volume, By End Users, 2022-2032 |
6.3.1 Overview & Analysis |
6.3.2 Global Animal Model Market, Revenues & Volume, By Pharma & Biotech Companies, 2022-2032 |
6.3.3 Global Animal Model Market, Revenues & Volume, By Academic Research Institutes, 2022-2032 |
6.3.4 Global Animal Model Market, Revenues & Volume, By Others, 2022-2032 |
7 North America Animal Model Market, Overview & Analysis |
7.1 North America Animal Model Market Revenues & Volume, 2022-2032 |
7.2 North America Animal Model Market, Revenues & Volume, By Countries, 2022-2032 |
7.2.1 United States (US) Animal Model Market, Revenues & Volume, 2022-2032 |
7.2.2 Canada Animal Model Market, Revenues & Volume, 2022-2032 |
7.2.3 Rest of North America Animal Model Market, Revenues & Volume, 2022-2032 |
7.3 North America Animal Model Market, Revenues & Volume, By Animal Type , 2022-2032 |
7.4 North America Animal Model Market, Revenues & Volume, By Application, 2022-2032 |
7.5 North America Animal Model Market, Revenues & Volume, By End Users, 2022-2032 |
8 Latin America (LATAM) Animal Model Market, Overview & Analysis |
8.1 Latin America (LATAM) Animal Model Market Revenues & Volume, 2022-2032 |
8.2 Latin America (LATAM) Animal Model Market, Revenues & Volume, By Countries, 2022-2032 |
8.2.1 Brazil Animal Model Market, Revenues & Volume, 2022-2032 |
8.2.2 Mexico Animal Model Market, Revenues & Volume, 2022-2032 |
8.2.3 Argentina Animal Model Market, Revenues & Volume, 2022-2032 |
8.2.4 Rest of LATAM Animal Model Market, Revenues & Volume, 2022-2032 |
8.3 Latin America (LATAM) Animal Model Market, Revenues & Volume, By Animal Type , 2022-2032 |
8.4 Latin America (LATAM) Animal Model Market, Revenues & Volume, By Application, 2022-2032 |
8.5 Latin America (LATAM) Animal Model Market, Revenues & Volume, By End Users, 2022-2032 |
9 Asia Animal Model Market, Overview & Analysis |
9.1 Asia Animal Model Market Revenues & Volume, 2022-2032 |
9.2 Asia Animal Model Market, Revenues & Volume, By Countries, 2022-2032 |
9.2.1 India Animal Model Market, Revenues & Volume, 2022-2032 |
9.2.2 China Animal Model Market, Revenues & Volume, 2022-2032 |
9.2.3 Japan Animal Model Market, Revenues & Volume, 2022-2032 |
9.2.4 Rest of Asia Animal Model Market, Revenues & Volume, 2022-2032 |
9.3 Asia Animal Model Market, Revenues & Volume, By Animal Type , 2022-2032 |
9.4 Asia Animal Model Market, Revenues & Volume, By Application, 2022-2032 |
9.5 Asia Animal Model Market, Revenues & Volume, By End Users, 2022-2032 |
10 Africa Animal Model Market, Overview & Analysis |
10.1 Africa Animal Model Market Revenues & Volume, 2022-2032 |
10.2 Africa Animal Model Market, Revenues & Volume, By Countries, 2022-2032 |
10.2.1 South Africa Animal Model Market, Revenues & Volume, 2022-2032 |
10.2.2 Egypt Animal Model Market, Revenues & Volume, 2022-2032 |
10.2.3 Nigeria Animal Model Market, Revenues & Volume, 2022-2032 |
10.2.4 Rest of Africa Animal Model Market, Revenues & Volume, 2022-2032 |
10.3 Africa Animal Model Market, Revenues & Volume, By Animal Type , 2022-2032 |
10.4 Africa Animal Model Market, Revenues & Volume, By Application, 2022-2032 |
10.5 Africa Animal Model Market, Revenues & Volume, By End Users, 2022-2032 |
11 Europe Animal Model Market, Overview & Analysis |
11.1 Europe Animal Model Market Revenues & Volume, 2022-2032 |
11.2 Europe Animal Model Market, Revenues & Volume, By Countries, 2022-2032 |
11.2.1 United Kingdom Animal Model Market, Revenues & Volume, 2022-2032 |
11.2.2 Germany Animal Model Market, Revenues & Volume, 2022-2032 |
11.2.3 France Animal Model Market, Revenues & Volume, 2022-2032 |
11.2.4 Rest of Europe Animal Model Market, Revenues & Volume, 2022-2032 |
11.3 Europe Animal Model Market, Revenues & Volume, By Animal Type , 2022-2032 |
11.4 Europe Animal Model Market, Revenues & Volume, By Application, 2022-2032 |
11.5 Europe Animal Model Market, Revenues & Volume, By End Users, 2022-2032 |
12 Middle East Animal Model Market, Overview & Analysis |
12.1 Middle East Animal Model Market Revenues & Volume, 2022-2032 |
12.2 Middle East Animal Model Market, Revenues & Volume, By Countries, 2022-2032 |
12.2.1 Saudi Arabia Animal Model Market, Revenues & Volume, 2022-2032 |
12.2.2 UAE Animal Model Market, Revenues & Volume, 2022-2032 |
12.2.3 Turkey Animal Model Market, Revenues & Volume, 2022-2032 |
12.3 Middle East Animal Model Market, Revenues & Volume, By Animal Type , 2022-2032 |
12.4 Middle East Animal Model Market, Revenues & Volume, By Application, 2022-2032 |
12.5 Middle East Animal Model Market, Revenues & Volume, By End Users, 2022-2032 |
13 Global Animal Model Market Key Performance Indicators |
14 Global Animal Model Market - Export/Import By Countries Assessment |
15 Global Animal Model Market - Opportunity Assessment |
15.1 Global Animal Model Market Opportunity Assessment, By Countries, 2022 & 2032F |
15.2 Global Animal Model Market Opportunity Assessment, By Animal Type , 2022 & 2032F |
15.3 Global Animal Model Market Opportunity Assessment, By Application, 2022 & 2032F |
15.4 Global Animal Model Market Opportunity Assessment, By End Users, 2022 & 2032F |
16 Global Animal Model Market - Competitive Landscape |
16.1 Global Animal Model Market Revenue Share, By Companies, 2025 |
16.2 Global Animal Model Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here